This article presents the results of studies of the therapeutic and prophylactic efficacy of the drug "Neoterica Protecto Syrup" for arachnoentomoses and nematodes of domestic carnivores. The drug contains the active ingredient moxidectin, which provides a wide range of antiparasitic action of the drug against ecto- and endoparasites. The studies were conducted from April to August 2020 in veterinary clinics in Moscow and the Moscow region on dogs and cats free from parasites and naturally infested with fleas, lice, ixodid and scabies mites, intestinal nematodes and dirofilaria larvae. The animals were administered the drug once orally individually at a therapeutic dose at the rate of 1.5 mg moxidectin per 1 kg of animal weight. The diagnosis and efficacy of the diseases were confirmed by clinical (examination of the skin and hair for the presence of ectoparasites) and laboratory (Priselkova's method for detecting acariform mites in scrapings, the "thick crushed drop method" for detecting dirofilariae, Fülleborn's method for detecting nematode eggs) studies have confirmed the therapeutic efficacy the drug, the antiparasitic activity persisted for 90 days after application, which confirms the preventive effectiveness of the drug.
This article presents the results of studies of the toxicological characteristics of a longacting veterinary medicinal product "Neoterica Protecto Syrup" based on moxidectin in the form of an oral solution. Acute oral toxicity was studied in white mice and white rats. As a result, the LD50 of the drug was 4300 mg/kg for male and female mice, 3500 mg/kg for male rats, and 5700 mg/kg for female rats, and on the basis of which it was established that the drug belongs to the 3rd hazard class (moderately hazardous substances) according to GOST 12.1.007-76. Acute cutaneous toxicity was investigated and the irritant effect of the drug on white rats was assessed, for the drug the 4th hazard class (low-hazard substances) was established according to GOST 12.1.007-76. The subchronic toxicity of doses of 1/10, 1/20 and 1/50 of the LD50 of the drug, established in an acute experiment, with daily use for 5 days was studied in white rats. As a result, it was found that doses of 350, 175 and 70 mg/kg with daily use in white outbred rats for 5 days are inoperative.
Aphanipterosis is a parasitic disease which is caused by fleas Siphonaptera parasitizing on an animal body. In 97 per cent of the cases the fleas Ctenocephalides canis and Ctenocephalides felis parasite on dogs and cats.The therapeutic efficacy of complex drugs «INSPECTOR QUADRO С» and «INSPECTOR QUADRO К» at aphanipterosis in dogs and cats was examined. The drugs were tested in veterinary clinics in Moscow and Volgograd. The drugs are in the form of topical solutions and contain fipronil, pyriproxyfen, praziquantel and moxidectin as active ingredients.The efficacy of drugs was studied on spontaneously infested dogs and cats. Before the experiment skin and hair of animals were examined and a quantity of ectoparasites (example/animal units) was defined. Dogs and cats were divided by the principle of couples analogs into two groups taking into account age, weight and the physiological status of an animal: experimental and control. The animals were treated once according to instructions for use. Monitoring of drug efficacy was carried out in 24 hours, 14 and 30 days after treatment. During researches animals were observed: the general condition, behavior, receiving of food and water, appearance of allergic reactions were noted, skin and hair were examined.Upon examination of dogs and cats infested by fleas, no fleas were found on skin and hair in 14 days after treatment. No living insects were found at further observation of experimental animals within 30 days. Thus, the therapeutic efficacy of complex drugs «INSPECTOR QUADRO С» and «INSPECTOR QUADRO К» at aphanipterosis in dogs and cats was 100%. No adverse effects and complications in animals were found.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.